Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 438

Similar articles for PubMed (Select 12941042)

1.

Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis.

Kitching AR, Turner AL, O'Sullivan KM, Dewerchin M, Lijnen HR.

J Thromb Haemost. 2003 Sep;1(9):1992-9.

PMID:
12941042
2.

Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis.

Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG.

J Exp Med. 1997 Mar 3;185(5):963-8.

3.

Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits.

Malliaros J, Holdsworth SR, Wojta J, Erlich J, Tipping PG.

Kidney Int. 1993 Sep;44(3):557-64.

PMID:
8231028
4.

Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis.

Kitching AR, Kong YZ, Huang XR, Davenport P, Edgtton KL, Carmeliet P, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2003 Jun;14(6):1487-95.

6.

Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.

Dewerchin M, Collen D, Lijnen HR.

Thromb Haemost. 2001 Aug;86(2):640-6.

PMID:
11522016
7.

Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.

Kitching AR, Tipping PG, Timoshanko JR, Holdsworth SR.

Kidney Int. 2000 Feb;57(2):518-25.

8.
9.

Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis.

Cunningham MA, Ono T, Hewitson TD, Tipping PG, Becker GJ, Holdsworth SR.

Kidney Int. 1999 Apr;55(4):1311-8.

10.

Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis.

Timoshanko JR, Sedgwick JD, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2003 Jul;14(7):1785-93.

11.

Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice.

Drew AF, Tucker HL, Liu H, Witte DP, Degen JL, Tipping PG.

Am J Physiol Renal Physiol. 2001 Dec;281(6):F1157-63.

12.

TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis.

Song CY, Kim BC, Hong HK, Lee HS.

Kidney Int. 2007 May;71(9):882-8. Epub 2007 Feb 14.

PMID:
17299519
13.

Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.

Lijnen HR, Okada K, Matsuo O, Collen D, Dewerchin M.

Blood. 1999 Apr 1;93(7):2274-81.

14.

Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.

Nagai N, De Mol M, Lijnen HR, Carmeliet P, Collen D.

Circulation. 1999 May 11;99(18):2440-4.

15.

Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.

Erlich JH, Apostolopoulos J, Wun TC, Kretzmer KK, Holdsworth SR, Tipping PG.

J Clin Invest. 1996 Jul 15;98(2):325-35.

16.

Antibody independent crescentic glomerulonephritis in mu chain deficient mice.

Li S, Holdsworth SR, Tipping PG.

Kidney Int. 1997 Mar;51(3):672-8.

PMID:
9067898
17.

IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment.

Kitching AR, Turner AL, Wilson GR, Semple T, Odobasic D, Timoshanko JR, O'Sullivan KM, Tipping PG, Takeda K, Akira S, Holdsworth SR.

J Am Soc Nephrol. 2005 Jul;16(7):2023-33. Epub 2005 May 11.

18.

Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta.

Hertig A, Berrou J, Allory Y, Breton L, Commo F, Costa De Beauregard MA, Carmeliet P, Rondeau E.

FASEB J. 2003 Oct;17(13):1904-6. Epub 2003 Aug 1.

19.

Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.

Okada K, Ueshima S, Tanaka M, Fukao H, Matsuo O.

Blood Coagul Fibrinolysis. 2000 Oct;11(7):645-55.

PMID:
11085285
20.

Apoptosis in progressive crescentic glomerulonephritis.

Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N.

Lab Invest. 1996 May;74(5):941-51.

PMID:
8642789
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk